Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Endocrine. 2013 Nov 28;46(2):318–327. doi: 10.1007/s12020-013-0093-x

Figure 1.

Figure 1

Representative IHC of EGFR and ErbB2 receptors in prolactinomas on tissue array (20× magnification). Top corner box shows magnification of selected area. EGFR staining was nuclear and ErbB2 staining membranous/cytoplasmic. Positive control tissue is breast cancer A. EGFR staining of prolactinoma B. EGFR staining of breast cancer (63× magnification). C. ErbB2 staining of prolactinoma D. ErbB2 staining of breast cancer (63× magnification).